Skip to content
Search

Latest Stories

Diageo’s India-born CEO Ivan Menezes to retire in June

Sir Menezes, an alumnus of the Indian Institute of Management-Ahmedabad, said he was “extremely proud� of what the company achieved during his time at the company

Diageo’s India-born CEO Ivan Menezes to retire in June

DIAGEO’S India-born CEO Sir Ivan Menezes will retire later this year, having led the spirit maker’s growth for 10 years.

Menezes, 63, will depart from the London-based company on June 30 and he will be succeeded by Debra Crew who is currently its chief operating officer, Diageo said in a statement on Tuesday (28).


Sir Ivan, a dual US-British citizen, joined the company in 1997 and held several senior positions overseeing its operations in the Americas and Asia Pacific. He became its executive director in 2012 and CEO a year later.

Diageo, whose popular brands include Guinness stout, Johnnie Walker whisky, Smirnoff vodka and Captain Morgan rum, said the FTSE100 company made “great strides” during his tenure.

“Diageo has grown significantly during this period… and is today the number one company by net sales value in Scotch whisky, vodka, gin, rum, Canadian whisky, liqueurs, and also tequila,” a category in which it had no substantive position eight years ago, it said.

It also credited the CEO with steering Diageo to a “leadership position” in sustainability.

Sir Ivan, an alumnus of the Indian Institute of Management Ahmedabad and Kellogg School of Management, said he was “extremely proud” of what the company achieved during his time at the company.

Diageo chairman Javier Ferrán said the CEO had transformed the spirit maker’s global footprint, brand portfolio and strategic focus, “positioning our business as a clear leader in premium drinks.”

“Ivan leaves Diageo extremely well positioned for future growth,” he said.

Sir Ivan spoke of his pride and honour in leading the company over the past decade.

“I am extremely proud of what we have achieved during that time, and I would like to thank my 28,000 talented colleagues around the world for all of their hard work, creativity and passion,” he added.

Under his leadership, Diageo grew into one of the world’s leading premium drinks company, accounting for 10 per cent (£2 billion) of the UK’s total food and drinks exports, according to the company.

It added that Sir Ivan championed women and ethnic diversity in business, with 47 per cent of Diageo’s executive committee being female and 47 per cent from an ethnic background.

Diageo’s share price has almost doubled on the London Stock Exchange since Sir Ivan took over as the CEO, but declined by about a per cent to 3,541.5p after the announcement of his retirement on Tuesday.

The executive, who was born in Pune, Maharashtra, was honoured with knighthood this year for his services to business and equality.

During the pandemic, Diageo supplied alcohol to make anti-bacterial hand sanitiser to boost stocks worldwide, mirroring other distilleries.

Crew, who will take over as the CEO on July 1, has been Diageo’s chief operating officer since October last year.

With the American executive's appointment to the role, the number of women CEOs running an FTSE 100 company will go up to 10.

She previously worked for PepsiCo, Kraft Foods, Nestlé and Mars, Inc.

More For You

modi-trump-getty
Trump shakes hands with Modi during a joint press conference at Hyderabad House in New Delhi on February 25, 2020. (Photo: Getty Images)

Key issues in India, US trade talks

TRADE talks between India and the US have hit a roadblock over disagreements on duties for auto components, steel and farm goods, Indian government sources said to Reuters, dashing hopes of reaching an interim deal ahead of president Donald Trump's July 9 deadline to impose reciprocal tariffs.

Here are the key issues at play:

Keep ReadingShow less
Anil Agarwal

Vedanta Resources, which is based in the UK and owned by Indian billionaire Anil Agarwal, has been working on reducing its debt. (Photo credit: Getty Images)

Getty Images

Anil Agarwal’s Vedanta Resources signs £438 million refinancing deal

VEDANTA LTD said on Thursday that its parent company, Vedanta Resources, has signed a loan facility agreement worth up to £438 million with international banks to refinance existing debt.

The refinancing move, where old loans are replaced by new ones, often at better terms like lower interest rates, has led ratings agencies such as S&P Global Ratings and Moody's to upgrade their outlook on the company this year.

Keep ReadingShow less
Trump-Getty

Trump said that while deals are being made with some countries, others may face tariffs.

Getty Images

Trump says major trade deal with India may be finalised soon

US PRESIDENT Donald Trump on Friday said a "very big" trade deal could be finalised with India, suggesting significant movement in the ongoing negotiations between the two countries.

“We are having some great deals. We have one coming up, maybe with India. Very big one. Where we're going to open up India," Trump said at the “Big Beautiful Bill” event at the White House.

Keep ReadingShow less
Asda suffers nearly £600m loss as debt and IT costs surge

Asda co-ownerMohsin Issa. (Photo: Asda)

Asda suffers nearly £600m loss as debt and IT costs surge

ASDA, one of Britain’s largest supermarkets, has reported a pre-tax loss of £599 million for 2024, swinging sharply from a £180 million profit the previous year.

The loss comes despite total sales rising by over £1 billion to £26.8bn, as the retailer faces mounting debt costs, falling sales, and spiralling spending on a major IT overhaul, the Telegraph reported.

Keep ReadingShow less
Mounjaro

Mounjaro, or tirzepatide, is part of a new class of weight-loss medications, with trials showing patients losing an average of 20 per cent of their body weight after 72 weeks.

Reuters

Lilly to sell Mounjaro pens in India as Wegovy enters market

ELI LILLY said on Thursday that it has received approval from India's drug regulator to launch pre-filled injector pens of its weight-loss drug, Mounjaro.

The move gives the company more options to compete with Novo Nordisk, which recently launched its weight-loss drug Wegovy in the country.

Keep ReadingShow less